Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.

Agwu AL, Bethel J, Hightow-Weidman LB, Sleasman JW, Wilson CM, Rudy B, Kapogiannis BG; ATN 061 Team and the Adolescent Medicine Trials Network for HIV/AIDS Interventions.

AIDS Patient Care STDS. 2012 Apr;26(4):193-6. No abstract available.

2.

Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.

Stanojevic M, Siljic M, Salemovic D, Pesic-Pavlovic I, Zerjav S, Nikolic V, Ranin J, Jevtovic D.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):634-41. doi: 10.1089/AID.2013.0270. Epub 2014 Apr 9.

3.

Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?

Estebanez M, Stella-Ascariz N, Ruiz-Carrascoso G, Zamora FX, García-Bujalance S, Bernardino JI, Pérez-Valero I, Martin-Quirós A, Mingorance J, Arribas JR.

AIDS. 2013 Jan 2;27(1):141-4. doi: 10.1097/QAD.0b013e328358fcc2.

PMID:
22914581
4.

High level of primary drug resistance in Mali.

Haidara A, Chamberland A, Sylla M, Aboubacrine SA, Cissé M, Traore HA, Maiga MY, Tounkara A, Nguyen VK, Tremblay C; Appuyer le Traitement Anti Rétroviral en Afrique de l'Ouest (ATARAO) Group 1.

HIV Med. 2010 Jul 1;11(6):404-11. doi: 10.1111/j.1468-1293.2009.00806.x. Epub 2010 Feb 8.

5.

Naturally occurring polymorphisms and primary drug resistance profile among antiretroviral-naive individuals in Bangalore, India.

Neogi U, Prarthana BS, Gupta S, D'souza G, De Costa A, Kuttiatt VS, Arumugam K, Shet A.

AIDS Res Hum Retroviruses. 2010 Oct;26(10):1097-101. doi: 10.1089/aid.2010.0092. Epub 2010 Sep 13.

PMID:
20836706
6.

Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India.

Chaturbhuj DN, Hingankar NK, Srikantiah P, Garg R, Kabra S, Deshmukh PS, Jadhav SD, Thorat SR, Datkar SR, Mehta P, Ingole N, Mathur M, Ramachandran A, Haldar P, Reddy DC, Bachani D, Rao S, Tripathy SP, Paranjape RS.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):927-32. doi: 10.1089/aid.2010.0032.

PMID:
20704495
7.

[Adherence, pharmacokinetic "tolerance capacity" and HIV resistance development].

Mossdorf E, Hirsch HH.

Praxis (Bern 1994). 2006 Aug 16;95(33):1237-9. German. No abstract available.

PMID:
16939126
8.

Drug-resistant genotyping in HIV-1 therapy.

Zöllner B, Feucht HH, Weitner L, Adam A, Laufs R.

Lancet. 1999 Sep 25;354(9184):1120-1. No abstract available.

PMID:
10509522
9.

Natural polymorphisms of integrase among HIV type 1-infected South African patients.

Fish MQ, Hewer R, Wallis CL, Venter WD, Stevens WS, Papathanasopoulos MA.

AIDS Res Hum Retroviruses. 2010 Apr;26(4):489-93. doi: 10.1089/aid.2009.0249.

PMID:
20377427
10.

Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.

Carvalho BC, Cardoso LP, Damasceno S, Stefani MM.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1081-7. doi: 10.1089/AID.2010.0334. Epub 2011 Apr 27.

PMID:
21417758
11.

Characterization of protease resistance-associated mutations in HIV type 1 drug-naive patients following the increasing prevalence of the CRF02_AG strain in Morocco.

Miri L, Ouladlahsen A, Kettani A, Bensghir R, Marhoum Elfilali K, Wakrim L.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):571-7. doi: 10.1089/AID.2011.0225. Epub 2012 May 3.

PMID:
22145994
12.

Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands.

Oliveira V, Bártolo I, Borrego P, Rocha C, Valadas E, Barreto J, Almeida E, Antunes F, Taveira N.

AIDS Res Hum Retroviruses. 2012 May;28(5):510-22. doi: 10.1089/AID.2011.0174. Epub 2011 Sep 19.

PMID:
21902592
13.

New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.

Zhao B, Han X, Dai D, Liu J, Ding H, Xu J, Chu Z, Bice T, Diao Y, Shang H.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1047-53. doi: 10.1089/AID.2010.0119. Epub 2011 May 6.

PMID:
21417755
14.

The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China.

Ye JR, Lu HY, Wang WS, Guo L, Xin RL, Yu SQ, Wu TC, Zeng Y, He X.

AIDS Res Hum Retroviruses. 2012 Apr;28(4):418-23. doi: 10.1089/aid.2011.0097. Epub 2011 Aug 10.

PMID:
21830915
15.

Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a cohort of Italian HIV-1 seropositive patients extensively treated with antiretroviral drugs.

Re MC, Borderi M, Monari P, Bon I, Gorini R, Gibellini D, Verucchi G, Fortunato L, Chiodo F, La Placa M.

Int J Antimicrob Agents. 2001 Dec;18(6):519-23.

PMID:
11738338
16.

Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria.

Ajoge HO, Gordon ML, Ibrahim S, Shittu OS, Ndung'u T, Olonitola SO.

AIDS Res Hum Retroviruses. 2012 Jan;28(1):115-8. doi: 10.1089/AID.2011.0115. Epub 2011 Jun 17.

PMID:
21568761
17.

Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infection.

Castro E, Recordon-Pinson P, Cavassini M, Fleury H.

Antivir Ther. 2012;17(3):593-4. doi: 10.3851/IMP2024. Epub 2012 Jan 25. No abstract available.

PMID:
22301389
18.

A case of apparent resistance to all available antiretroviral drugs in a HIV-positive patient.

Chibo D, Roth N, Birch C.

Sex Health. 2010 Mar;7(1):82-4. doi: 10.1071/SH09032.

PMID:
20152102
19.

Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa.

Nwobegahay J, Selabe G, Ndjeka NO, Manhaeve C, Bessong PO.

J Med Virol. 2012 Dec;84(12):1839-43. doi: 10.1002/jmv.23348.

PMID:
23080485
20.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM; AERI study Group.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):482-9. doi: 10.1016/j.eimc.2011.03.001. Epub 2011 May 2.

PMID:
21543135

Supplemental Content

Support Center